Business

The Closing Date of GB Sciences' Sale of GB Sciences Louisiana LLC Is Delayed

The Closing Date of GB Sciences' Sale of GB Sciences Louisiana LLC Is Delayed.

articleGb Sciences, Inc.November 6, 20195/company/gb-sciences-inc/news/the-closing-date-of-gb-sciences-sale-of-gb-sciences-louisiana-llc-is-delayed
The Closing Date of GB Sciences' Sale of GB Sciences Louisiana LLC Is Delayed

About this update from Gb Sciences, Inc.

[{"type":"text","content":"\n\n\n\nThe Closing Date of GB Sciences' Sale of GB Sciences Louisiana LLC Is Delayed\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nThe Closing Date of GB Sciences' Sale of GB Sciences Louisiana LLC Is Delayed\nPR Newswire\nLAS VEGAS, Nov. 6, 2019\n\n\n\n LAS VEGAS, Nov. 6, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) announces a delay in the sale of GB Sciences Louisiana LLC.  \n\n \n \n\n \nOn September 16, 2019, GB Sciences, Inc. (the \"Company\"), filed a Current Report on Form 8-K disclosing that the Company had signed a term sheet with K2 Logic, LLC (\"K2\") pursuant to which K2 will pursue the purchase of the Company's 50% ownership interest in GB Science Louisiana, LLC for $8,000,000 in cash and earn out provisions for up to an additional $8,000,000. The parties were to negotiate and draft a Purchase and Sale Agreement with the intent to close the transaction by October 31, 2019. The parties were not prepared to close on October 31, 2019, and have now extended the closing date to on or before November 30, 2019.\nAbout GB Sciences, Inc.\nGB Sciences, Inc. (OTCQB: GBLX) is a diverse cannabis company, focused on standardized cultivation and production methods; as well as biopharmaceutical research and development. The Company's goal is creating safe, standardized, pharmaceutical-grade, cannabinoid therapies that target a variety of medical conditions. To learn more about GB Sciences, Inc., go to: http://gbsciences.com.\nForward-Looking Statements\nThis press release may contain statements relating to future results or events, which are forward-looking statements.  Words such as \"expects\", \"intends\", \"plans\", \"may\", \"could\", \"should\", \"anticipates\", \"likely\", \"believes\" and words of similar import may identify forward-looking statements. These statements are not historical facts, but instead represent only the Company's belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the Company's control.  It is possible that the Company's actual results and financial conditi...

More updates from Gb Sciences, Inc.